Speaker illustration

Mr Ruben Tijssen

Academic Medical Centre, Amsterdam (Netherlands (The))

Clinical outcomes at two years of the Absorb BRS vs. the Xience metallic DES in patients presenting with ACS vs. stable coronary disease - AIDA trial substudy

Event: ESC CONGRESS 2019

Topic: Revascularisation

Session: Innovative strategies in percutaneous coronary intervention


ESC 365 is supported by

logo Novo Nordisk